Recorded device evidence

Zimmer® Persona® Personalized Knee System (K243293): indications, design and recorded evidence

The acquired K243293 file contains product-specific indications and users, design and operating principle, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 37 selected decisions under primary code MBH. 37 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

Calendar elapsed days: lower quartile 52.0, median 83.0, upper quartile 127.0. These are recorded calendar differences, not active FDA review time.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K243293 ↗ · this pageZimmer® Persona® Personalized Knee System2024-10-18 → 2024-12-2063Traditional
K261275 ↗Unity Total Knee System, Unity Knee Cementless CR Femur2026-04-17 → 2026-09-17153Traditional
K261462 ↗LANDMARK Total Knee System2026-05-04 → 2026-09-08127Traditional
K253728 ↗EVOLUTION® AM BIOFOAM® Tibial System2025-11-24 → 2026-08-21270Traditional
K251840 ↗Zimmer® Persona® Personalized Knee System2025-06-16 → 2026-05-28346Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K243293 · PDF page 4 ↗ Source 2

When a  mechanical  alignment approach  is utilized , this  device  is    indicated for patients with    severe
    knee   pain   and disability due to:
   • Rheumatoid arthritis,   osteoarthritis,   traumatic arthritis ,  polyarthritis.
   • Collagen disorders,  and/or avascular necrosis of the femoral    condyle.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K243293 · PDF page 6 ↗ Source 3

The Persona Personalized Knee System is a
                                               semiconstrained modular knee prosthesis designed to
                                               resurface the articulating surface of the femoral, tibial, and
                                               patellar bones.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Performance evidence actually described

K243293 · PDF page 8 ↗ Source 4

(Nonclinical and/or Clinical):
                                                    The performance data provided in the performance
                                                    testing section indicate the proposed devices meet the
                                                    established acceptance criterion; therefore, are as safe
                                                    and effective and substantially equivalent to the legally
                                                    marketed predicate devices from a performance
                                                    standpoint.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK243293 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryZimmer® Persona® Personalized Knee System [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantZimmer Biomet [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeMBH [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2024-12-20 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2024-10-18 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

What needs to happen first

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[22035] · record 35b728af0713021a5ed41e34e5c74d5f3df4812d67b6fafa35d98891d6b55a74
  • [5] Complete results array / fda-decision-context:K243293 · record whole dataset partition

FDA 510(k) summary — K243293 ↗

Sat, 21 Dec 2024 18:59:32 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot d85dbfa498bce6bd28a7bf1f95c4617b79459a21115380c879b917723f31de71

  • [2] PDF page 4 · record 8c161d2b1283c0a8d796ba04e579d054a2f8461be16b81feb0026539ba65b0ee
  • [3] PDF page 6 · record 1f41f170d217f630fb2a3cca1d18fc7cacda928d33dadd90c8c7c0cacb4d0aa2
  • [4] PDF page 8 · record 3f44157864d1f4cab4f762016ded18b20e8cd9ef296aa522db17692b1fdac9b9

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services

Packaging + Shelf-life + Distribution Testing